Search Results | DrugBank Online

Displaying drugs 13651 - 13675 of 14606 in total

FB-101

FB-101 is a c-Abl inhibitor. Developed by 1st Biotherapeutics, it is being investigated for the treatment of neurological disorders, such as Parkinson's Disease and amyotrophic lateral sclerosis (ALS).

Experimental

Investigational

Matched Description: … , it is being investigated for the treatment of neurological disorders, such as Parkinson's Disease and …

Acetyl Dithranol

Experimental

CRA_10762

Experimental

Oxidized Acetyl Dithranol

Experimental

(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine

Experimental

N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide

Experimental

4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose

Experimental

Allosamizoline

Experimental

1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID

Experimental

(5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one

Experimental

ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE

Experimental

Thienylfentanyl

Thienylfentanyl is a fentanyl analog analgesic that was sold on the black market in the 1980s until the Federal Analog Act scheduled drugs based on structural similarity rather than scheduling drugs individually. Thienylfentanyl has a similar synthesis pathway to fentanyl except 2-(2-bromoethyl)thiophene is substituted for phenethyl bromide.

Illicit